Abstract
-
Keywords
References
- 1. Galel SA, Malone III JM, Viele MK. Transfusion Medicine. In: Greer JP, Foerster J, Lukens JN, eds. Wintrobe’s Clinical Hematology, 11th Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. Volume 1: 862-863.
- 2. Elder D, Elenitsas R, Jaworsky C, Johnson B. Histopathology Of The Skin. Lippincott-Raven. 8th Ed. Philadelphia, 1997: 240-244.
- 3. Carey PM, Sacher RA. Transfusion-associated graft versus host disease. In: Simon TL, Dzik WH, Synder EL, et al., eds. Rossi’s Principles of Transfusion Medicine, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2002: 852-864.
- 4. Brubaker DB. Human posttransfusion graft versus host disease. Vox Sang 1983; 45: 401-420.
- 5. Anderson KC, Weinstein HJ. Transfusion-associated graft versus host disease. N Engl J Med 1990; 323: 315- 321.
- 6. Petz LD, Calhoun P, Yam M, et al. Transfusionassociated graft versus host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a 2nd degree relative, and a survey of predisposing factors. Transfusion 1993; 33: 742-750.
- 7. McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion-associated graft versus host disease. Transfus Med Rev 1993; 7: 37-41.
- 8. Schroeder ML. Transfusion-associated graft versus host disease. Br J Haematol 2002; 117: 275-287.
İMMUNKOMPETAN BİR HASTADA ORTOPEDİK CERRAHİ SONRASI GELİŞEN TRANSFÜZYONLA İLİŞKİLİ GRAFT VERSUS HOST HASTALIĞI
Abstract
Transfüzyonla ilişkili Graft versus Host Hastalığı, genellikle hücresel immünitesi bozulmuş bireylerde histokompatibl olmayan lenfoid hücrelerin transfüzyonu sonrası gelişen, iyi bilinen fakat nadir bir komplikasyondur. İmmünitesi sağlam olan bireylerde de nadiren görülebilir. Ateş, cilt döküntüsü, diyare, karaciğer fonksiyon bozukluğu ve kemik iliği aplazisi bu hastalığın klinik tablosunu oluşturur. Hemen her zaman ölümcül seyreder. Burada, sağ koksartroz nedeniyle ortopedik cerrahi sırasında birinci ve ikinci derece akrabalarından kan transfüzyonu yapılan immünkompetan bir hastadaki ölümcül seyreden Transfüzyonla ilişkili Graft versus Host Hastalığı olgusu sunulmuştur.Anahtar Kelimeler: Transfüzyonla ilişkili graft versus host hastalığı, immünkompetan, döküntü
References
- 1. Galel SA, Malone III JM, Viele MK. Transfusion Medicine. In: Greer JP, Foerster J, Lukens JN, eds. Wintrobe’s Clinical Hematology, 11th Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. Volume 1: 862-863.
- 2. Elder D, Elenitsas R, Jaworsky C, Johnson B. Histopathology Of The Skin. Lippincott-Raven. 8th Ed. Philadelphia, 1997: 240-244.
- 3. Carey PM, Sacher RA. Transfusion-associated graft versus host disease. In: Simon TL, Dzik WH, Synder EL, et al., eds. Rossi’s Principles of Transfusion Medicine, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2002: 852-864.
- 4. Brubaker DB. Human posttransfusion graft versus host disease. Vox Sang 1983; 45: 401-420.
- 5. Anderson KC, Weinstein HJ. Transfusion-associated graft versus host disease. N Engl J Med 1990; 323: 315- 321.
- 6. Petz LD, Calhoun P, Yam M, et al. Transfusionassociated graft versus host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a 2nd degree relative, and a survey of predisposing factors. Transfusion 1993; 33: 742-750.
- 7. McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion-associated graft versus host disease. Transfus Med Rev 1993; 7: 37-41.
- 8. Schroeder ML. Transfusion-associated graft versus host disease. Br J Haematol 2002; 117: 275-287.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Case Reports |
| Authors | |
| Publication Date | June 26, 2015 |
| Published in Issue | Year 2006 Volume: 19 Issue: 1 |